Post job

Genocea CEO and executives

Executive Summary. Based on our data team's research, Chip Clark is the Genocea's CEO. Genocea has 59 employees, of which 26 are in a leadership position.
Here are further demographic highlights of the leadership team:
  • The Genocea executive team is 46% female and 54% male.
  • 59% of the management team is White.
  • 9% of Genocea management is Hispanic or Latino.
  • 9% of the management team is Black or African American.
Work at Genocea?
Share your experience

Rate Genocea's leaders' effectiveness in guiding the company.

Zippia waving zebra
Name & TitleBio
Chip Clark

President and Chief Executive Officer

Chip Clark's LinkedIn

Prior to joining Genocea,Chip co-founded and served as Chief Business Officer of Vanda Pharmaceuticals, Inc. (NASDAQ: VNDA). Before that, Chip was a Principal at Care Capital, LLC, a venture capital firm investing in biopharmaceutical companies, after serving in a variety of commercial roles at SmithKline Beecham (now GlaxoSmithKline). Chip holds a B.A. from Harvard University and an M.B.A. from The Wharton School at the University of Pennsylvania.

David A. Sinclair

Founder

Josh Wolfe

Founder

Kevin Bitterman

Board Member

George Siber M.d

Board Member

Jessica Baker Flechtner

Chief Scientific Officer

Jessica Baker Flechtner's LinkedIn

Charismatic, articulate, and driven leader with a proven track record of strategic and tactical thinking, effective communication, asset management and prioritization, project leadership, intellectual property analysis, and vaccine and cell therapy development.

Katrine S. Bosley

Board Member

Kenneth M. Bate

Chairman

Diantha Duvall

Chief Financial Officer

Michael John Higgins

Board Member

Do you work at Genocea?

Does leadership effectively guide Genocea toward its goals?

Genocea jobs

Genocea founders

Name & TitleBio
David A. Sinclair

Founder

Josh Wolfe

Founder

Kevin Bitterman

Board Member

Genocea board members

Name & TitleBio
Chip Clark

President and Chief Executive Officer

Chip Clark's LinkedIn

Prior to joining Genocea,Chip co-founded and served as Chief Business Officer of Vanda Pharmaceuticals, Inc. (NASDAQ: VNDA). Before that, Chip was a Principal at Care Capital, LLC, a venture capital firm investing in biopharmaceutical companies, after serving in a variety of commercial roles at SmithKline Beecham (now GlaxoSmithKline). Chip holds a B.A. from Harvard University and an M.B.A. from The Wharton School at the University of Pennsylvania.

Josh Wolfe

Founder

Kevin Bitterman

Board Member

George Siber M.d

Board Member

Katrine S. Bosley

Board Member

Kenneth M. Bate

Chairman

Michael John Higgins

Board Member

Jennifer L. Herron

Board Member

John Lunger

Board Member

Elizabeth Jaffee

Board Member

Genocea executives FAQs

Zippia gives an in-depth look into the details of Genocea, including salaries, political affiliations, employee data, and more, in order to inform job seekers about Genocea. The employee data is based on information from people who have self-reported their past or current employments at Genocea. The data on this page is also based on data sources collected from public and open data sources on the Internet and other locations, as well as proprietary data we licensed from other companies. Sources of data may include, but are not limited to, the BLS, company filings, estimates based on those filings, H1B filings, and other public and private datasets. While we have made attempts to ensure that the information displayed are correct, Zippia is not responsible for any errors or omissions or for the results obtained from the use of this information. None of the information on this page has been provided or approved by Genocea. The data presented on this page does not represent the view of Genocea and its employees or that of Zippia.

Genocea may also be known as or be related to GENOCEA BIOSCIENCES INC., GENOCEA BIOSCIENCES, INC., Genocea, Genocea Biosciences, Genocea Biosciences Inc, Genocea Biosciences Inc. and Genocea Biosciences, Inc.